Literature DB >> 14526178

Molecular genetics of spinocerebellar ataxia type 8 (SCA8).

A K Mosemiller1, J C Dalton, J W Day, L P W Ranum.   

Abstract

We previously reported that a transcribed but untranslated CTG expansion causes a novel form of ataxia, spinocerebellar ataxia type 8 (SCA8) (Koob et al., 1999). SCA8 was the first example of a dominant spinocerebellar ataxia that is not caused by the expansion of a CAG repeat translated into a polyglutamine tract. This slowly progressive form of ataxia is characterized by dramatic repeat instability and a high degree of reduced penetrance. The clinical and genetic features of the disease are discussed below. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526178     DOI: 10.1159/000072852

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  7 in total

1.  Spinocerebellar ataxia with sensory neuropathy (SCA25).

Authors:  Giovanni Stevanin; Emmanuel Broussolle; Nathalie Streichenberger; Nicolas Kopp; Alexis Brice; Alexandra Durr
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

2.  Bidirectional expression of the SCA8 expansion mutation: one mutation, two genes.

Authors:  Yoshio Ikeda; Randy S Daughters; Laura P W Ranum
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

3.  Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia.

Authors:  Yoshio Ikeda; Joline C Dalton; Melinda L Moseley; Kathy L Gardner; Thomas D Bird; Tetsuo Ashizawa; William K Seltzer; Massimo Pandolfo; Aubrey Milunsky; Nicholas T Potter; Mikio Shoji; John B Vincent; John W Day; Laura P W Ranum
Journal:  Am J Hum Genet       Date:  2004-05-19       Impact factor: 11.025

4.  Structural roles of CTG repeats in slippage expansion during DNA replication.

Authors:  Lai Man Chi; Sik Lok Lam
Journal:  Nucleic Acids Res       Date:  2005-03-14       Impact factor: 16.971

Review 5.  Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases.

Authors:  Bindu Prabhakar; Xiao-Bo Zhong; Theodore P Rasmussen
Journal:  Yale J Biol Med       Date:  2017-03-29

Review 6.  The Contribution of Somatic Expansion of the CAG Repeat to Symptomatic Development in Huntington's Disease: A Historical Perspective.

Authors:  Darren G Monckton
Journal:  J Huntingtons Dis       Date:  2021

7.  Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci.

Authors:  I-Cheng Chen; Hsuan-Yuan Lin; Ghin-Chueh Lee; Shih-Huan Kao; Chiung-Mei Chen; Yih-Ru Wu; Hsiu-Mei Hsieh-Li; Ming-Tsan Su; Guey-Jen Lee-Chen
Journal:  BMC Mol Biol       Date:  2009-02-10       Impact factor: 2.946

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.